Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Clinical trial NCT06239311 · RECRUITING

Trial details

NCT number: NCT06239311
Sponsor: medac GmbH
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate to Severe Atopic Dermatitis

Start date: 2024-02-27
Primary completion: 2026-11-01
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.